Buchholz, Tonia J.
Bristol-Myers Squibb (United States)
2 papers on CoChat
Most cited papers
- Verified
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier
Carpio, C., Bouabdallah, R., Ysebaert, L., Sancho, J.-M., Salles, G., Cordoba, R., Pinto, A., Gharibo, M., Rasco, D., Panizo, C., et al. (2020) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 72
- Verified
Clinical Activity of BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma (MM): First Results from a Phase 1, Multicenter, Open-Label Study
Bal, S., Kocoglu, M. H., Nadeem, O., Htut, M., Gregory, T., Anderson, L. D., Costa, L. J., Buchholz, T. J., Ziyad, S., Li, M., et al. (2022) · Blood
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 38
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free